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Abstract
Background: The association between serum selenium levels and type 2 diabetes mellitus (T2DM) is controversial. We
performed a systematic review and non-linear dose–response meta-analysis of observational studies to investigate the
association in the present study.
Methods: A comprehensive literature search was conducted using MEDLINE and EMBASE databases. A pooled odds
ratio (OR) and related 95 % confidence interval (95 % CI) for T2DM between the highest and lowest serum selenium
categories, and a non-linear dose–response relationship between selenium and T2DM were estimated.
Results: A total of five studies (of 13,460 participants) were identified as meeting the inclusion criteria. The pooled OR
indicated that there was a significantly higher prevalence of T2DM in the highest category of blood selenium compared
with the lowest (OR = 1.63, 95 % CI: 1.04–2.56, P = 0.033). Moreover, a significant non-linear dose–response relationship
was observed between serum selenium levels and T2DM (P < 0.001). Serum selenium levels were positively associated
with T2DM in populations with relatively low serum selenium levels (<97.5 μg/l) and those with high serum selenium
levels (>132.5 μg/l).
Conclusions: The positive association between serum selenium levels and T2DM existed in populations with relatively
low levels and high levels of serum selenium, indicating a likely U-shaped non-linear dose–response relationship between
serum selenium and T2DM.
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Background
Selenium is one of the most essential trace elements for hu-
man health. It functions as a redox center as part of the
family of selenium-dependent glutathione peroxidases
(GPx), transforming hydrogen peroxide and damaging lipid
and phospholipid hydroperoxides into harmless products
[1–3]. It is also a basic component of selenoproteins, which
are a group of critically important enzymes [1]. In its pro-
tective role against oxidative stress, selenium has drawn
increasing attention for preventing type 2 diabetes mellitus
(T2DM), cardiovascular disease, cancer, and other chronic
diseases [4–6]. Low selenium levels are thought to contrib-
ute to disease etiology, or may be a consequence of disease
that aggravates the condition further [1].
T2DM is the most common form of diabetes, and is
caused by a progressive insulin secretory defect against a
background of insulin resistance [7]. Its relationship with
oxidative stress may reflect the excess levels of reactive
oxygen species in hyperglycemia. Oxidative stress has a
huge impact on the etiology, pathogenesis, and complica-
tions of T2DM [8, 9]. In view of the protective function of
selenium against oxidative stress, selenium might be
expected to play a protective role against T2DM. How-
ever, the relationship between selenium and T2DM is
highly complex. The over-expression of GPx in islets may
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protect pancreatic β cells from oxidative stress, stimulate
pancreatic β cell gene expression, and improve islet func-
tion [10–12]. Conversely, high selenium concentrations in
the human body may interfere with insulin signaling,
which is critical to the regulation of glucose levels and the
prevention of diabetes [13, 14].
Many researchers have investigated the effects of blood
selenium levels on T2DM, but the conclusions are contro-
versial. Some studies report that blood selenium is nega-
tively associated with T2DM [15–23], while others indicate
a positive correlation [24–28]. Meanwhile, no significant
association is documented by other reports [29–34]. Be-
cause of this complicated relationship between selenium
and T2DM, we hypothesized that it might not be linear.
Additionally, the selenium status and intake vary widely in
different parts of the world [1], which might cause the in-
consistencies observed in study outcomes.
A previous review article [5] suggested that there
might be no standard or specific definition for serum or
plasma selenium deficiencies. However, recommenda-
tions for dietary selenium intake are available, advising
an average of 60 μg per day for men and 53 μg per day
for women [35]. Several previous studies indicated that
individuals with serum or plasma selenium concentra-
tions of 122 μg/L or higher should not supplement with
selenium [36, 37]. Conversely, those with serum or
plasma selenium concentrations lower than 122 μg/L
could benefit from increased levels (up to 130–150 μg/
L), which would reduce their mortality [38]. However,
these findings were based on qualitative estimations, and
the relationship between serum selenium levels and
T2DM remains unclear.
Therefore, the objective of the present research was to
comprehensively review the evidence on the association
between serum selenium levels and T2DM by conduct-




This meta-analysis was conducted following Preferred
Reporting Items for Systematic Reviews and Meta-
analyses guidelines. MEDLINE and EMBASE databases
were searched in September 2015 to identify relevant
observational studies that investigated the relationship
between blood selenium levels and T2DM. Search key
words included “diabetes mellitus”, “T2DM”, “NIDDM”,
and “selenium”. The specific search strategies are listed
in Additional file 1: Appendix 1.
Study selection
Two researchers independently reviewed all citations and
abstracts generated by the literature search. Qualified
studies were subsequently examined for inclusion. Each
researcher independently assessed the full texts in a
blinded and standardized manner using a customized
form to determine whether all inclusion criteria were
met. Disagreements were resolved by discussion to
reach a consensus.
Studies that met the following criteria were included:
1) observational comparative studies relating to the asso-
ciation between blood selenium levels and T2DM; 2)
patients diagnosed with confirmed T2DM; 3) the expos-
ure of interest was serum selenium levels, and at least
three quantitative categories of selenium levels were
classified; 4) the selenium level for each response cat-
egory was provided or could be calculated; 5) the study
reported numbers of cases and controls for each serum
selenium category; and 6) full research articles. Exclusion
criteria were: 1) patients with type 1 diabetes mellitus or
gestational diabetes; 2) randomized controlled trials in-
vestigating the effect of selenium supplementation on
T2DM; 3) review articles; 4) in vitro studies and animal
experiments; and 5) short reports or meeting abstracts.
Data extraction and quality assessment
The following background information was extracted
from the included studies: first author, publication year,
country, study design, setting, study population, sample
size, basic characteristics of participants (age, sex, and
body mass index), and selenium classification. Data on
the number of cases and participants in different selen-
ium categories, and the odds ratios (ORs) of incidence/
prevalence of T2DM between the highest and the lowest
selenium category were extracted for analysis.
The methodological quality of included studies was
evaluated by the Newcastle–Ottawa Scale (NOS) [39],
which was developed to assess the quality of non-
randomized studies based on three broad perspectives:
selection of the study groups; comparability among dif-
ferent groups; and the ascertainment of either the expos-
ure or outcome of interest. The total NOS score ranged
from 0 to 9 based on the assessment items. Studies scor-
ing higher than 6 were considered to have a high meth-
odological quality.
Statistical analysis
The association between blood selenium levels and
T2DM was evaluated by the pooled OR and related 95 %
confidence interval (95 % CI) for T2DM between the
highest and lowest selenium categories. The heterogeneity
of effect size across studies was tested by the Q statistic
(P < 0.05 was considered heterogeneous) or I2 statistic
(I2 > 50 % was considered heterogeneous). The random
effects model was used if significant heterogeneity was
detected among studies; otherwise, the fixed effects model
was applied. Sensitivity analysis was conducted to examine
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the influence of specific exclusion criteria on the overall
effect size. Begg’s tests [40] and funnel plots were per-
formed to assess publication bias.
A two-stage random effects dose–response meta-
analysis was conducted to investigate the potential
non-linear dose–response relationship between blood
selenium levels and T2DM [41]. First, a restricted
cubic splines model with four knots at percentiles 5,
35, 65, and 95 % of the distribution was adopted using
generalized least squares regression. Then, the re-
stricted maximum likelihood method in a random ef-
fects meta-analysis was adopted to calculate the
pooled study-specific estimates [42–44]. The median
or mean selenium concentration for each category was
assigned to each corresponding OR with 95 % CI.
When only the range of the selenium concentration
was reported, the mid-point of the range was adopted
to represent the category. When the category was
open-ended, we assumed the open-ended interval
length was the same as the adjacent interval [45, 46].
Statistical analyses were performed using STATA ver-
sion 11.0 (StataCorp LP, College Station, TX). P < 0.05
was considered to be statistically significant.
Statistical analysis
The association between blood selenium level and
T2DM were evaluated by a pooled OR and related 95 %
confidence interval (95 % CI) for T2DM between the
highest and the lowest selenium category. The hetero-
geneity of effect size across studies was tested by Q stat-
istic (p < 0.05 was considered heterogeneous) or I2
statistic (I2 > 50 % was considered heterogeneous). If
there was a significant heterogeneity among studies, the
random-effects model was used; otherwise, the fixed-
effects model was applied. A sensitivity analysis was con-
ducted to examine the influence of specific exclusion
criteria on the overall effect sizes. Begg’s tests [40] and
funnel plot was performed to assess the publication bias.
For the potential non-linear dose–response relation-
ship between blood selenium level and T2DM, a 2-stage,
random effects, dose–response meta-analysis was con-
ducted [41]. Firstly, restricted cubic splines model with
four knots at percentiles 5, 35, 65 and 95 % of the distri-
bution was adopted by using generalized least squares
regression. Then the restricted maximum likelihood
method in a random-effects meta-analysis was adopted
to calculate the pooled study-specific estimates [42–44].
The median or mean selenium concentration for each
category was assigned to each corresponding ORs with
95 % CI. When only range of selenium concentration
was reported, the mid-point of the range was adopted
for representing the category. When the category was
open-ended, we assumed the open-ended interval length
to be the same as the adjacent interval [45, 46].
Statistical analyses were performed using STATA ver-
sion 11.0 (StataCorp LP, College Station, Texas). P < 0.05
was considered to be statistically significant.
Results
Literature search
Figure 1 shows the selection process of the observational
studies included in this study. A total of 1404 records
were selected following the search strategies. After re-
moving duplicate records, 991 abstracts and titles were
initially identified. Of these, 948 records were excluded
because they did not meet inclusion criteria, and the
remaining 43 full-text studies were evaluated for eligibil-
ity. Eventually, a total of five studies were included in
this research.
Study characteristics
The characteristics of the included studies and subjects
are shown in Table 1. A total of 13,460 participants were
included within the five studies [25, 27, 28, 32, 47]. The
studies were published from 1998 to 2015; two were
conducted in the United States [25, 27], two in Sweden
[32, 47], and one in Italy [28]. Three studies were longi-
tudinal studies [28, 32, 47], but two of these were con-
sidered to be cross-sectional because the data were
extracted from baseline [28, 47]. The remaining two
studies were also cross-sectional [25, 27]. The commu-
nity population was targeted in all included studies, and
1404 records were  identified by search 
Excluded 413 duplicate records 
991 abstracts and titles were screened 
948 were excluded
Irrelevant 767
Animal or experimental research 87
Review article 39




43 full articles were evaluated
38 were excluded
Not diagnosis with type-2 diabetes mellitus 4
Selenoprotein P 5
Repeated research 1
unbalance between two groups 1
Short reports/meeting abstracts 9
No selenium classification 18
Eventually, 5 observational researches were 
included in the present study
Fig. 1 Flow chart of the selection process of the included studies
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Table 1 Characteristics of studies included in the meta-analysis
First author,
year and country
















of inhabitants in the south-
east of Sweden.















Defined as a fasting plasma glucose≥ 126 mg/dl, a self-report








tion from NHANES 2003–2004
890 54.4 47.0 28.8 Quartiles: <124,
124–133, 134–146,
>146 μg/l
Defined as the presence of either a self-report of current use of













445 50.9 100 26.8 Tertiles: <69.7,
69.7–82.6, > 82.6 μg/l







men living in Uppsala County,
Sweden.
1925 49.7 100 25.0 Tertiles: 61.4, 75.1,
91.1 μg/la
Defined by elevated fasting glucose levels and/or use
of anti-diabetic medicine. Elevated glucose levels were
assessed as fasting blood glucose ≥6.1 mmol/l at the age
60 years’ examination (equals ≥7.0 mmol/l of plasma glucose)
and fasting plasma glucose ≥ 7.0 mmol/l at age 70 years and
age 77 years
Abbreviations: NHANES National Health and Nutrition Examination Survey, NR not report











the sample size varied from 445 to 8876. The methodo-
logical quality, based on NOS, is reported in Table 2. All
studies were evaluated with a high methodological qual-
ity: three studies scored 9 and two studies scored 7.
OR for T2DM between different serum selenium
categories
The pooled data analysis indicated that there was a
significantly higher prevalence of T2DM in the highest
category of blood selenium compared with the lowest
(OR = 1.63, 95 % CI: 1.04–2.56, P = 0.033, Fig. 2). Unfor-
tunately, significant heterogeneity was observed among
different studies (P = 0.009, I2 = 70.3 %). No evidence
of publication bias was observed according to the Begg
rank-correlation test among the included studies (P =
0.221). The Begg’s funnel plot is shown in Additional
file 1: Appendix 2.
Because of the substantial degree of heterogeneity among
studies, a qualitative analysis was adopted. As shown in
Fig. 3, a significant association was observed between high
serum selenium concentrations and increased prevalence of
T2DM in studies including participants with relatively high
selenium concentrations [25, 27]. Studies conducted in par-
ticipants with relatively lower selenium concentrations did
not show a significant association between serum selenium
concentration and T2DM [28, 32, 47]. We also performed
a sensitivity analysis by excluding one study [27] that was
an outlier; the outcome suggested a similar positive associ-
ation between T2DM and serum selenium (OR= 1.32,
95 % CI: 1.12–1.54, P = 0.001) but with a significantly de-
creased level of heterogeneity (P = 0.495, I2 = 0 %).
Non-linear dose–response relationship between blood
selenium and T2DM
A significant non-linear dose–response relationship be-
tween blood selenium levels and T2DM was found (P <
0.001 for nonlinearity; Fig. 4). The reference selenium
level was 52.5 μg/l. When serum selenium concentrations
exceeded 132.5 μg/l, they were strongly positively associ-
ated with increased prevalence of T2DM. There was also
Table 2 Methodological quality assessment according to Newcastle-Ottawa Scale (NOS)






























1 1 1 1 0 1 1 1 7
Bleys 2007 1 1 1 1 2 1 1 1 9
Gao 2014 1 1 1 1 2 1 1 1 9
Laclaustra
2009
1 1 1 1 2 1 1 1 9
Stranges
2011
1 1 1 1 0 1 1 1 7
NOTE: Weights are from random effects analysis
























Fig. 2 Forest plot of OR for T2DM between the highest and lowest serum selenium category
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a moderately positive association between serum selenium
and T2DM when individuals had relatively low levels of
serum selenium (<97.5 μg/l). However, the positive associ-
ation began to disappear with a flattening of the curve at
the middle level (97.5–132.5 μg/l) of serum selenium.
Discussion
To the best of our knowledge, this is the first systematic
review and dose–response meta-analysis examining the
association between serum selenium levels and T2DM
based on previous observational studies. We found a
significantly higher prevalence of T2DM in the highest
category of blood selenium compared with the lowest,
and serum selenium levels were positively associated
with T2DM in populations with relatively low (<97.5 μg/
l) or high serum selenium levels (>132.50 μg/l).
Previous evidence about the relationship between sel-
enium and T2DM is conflicting. Some studies claim that
patients with T2DM have significantly lower selenium
concentrations compared with healthy subjects [15–23].
Antioxidants in non-diabetic individuals can mitigate
free radical-mediated oxidative stress, but in the chronic
hyperglycemia state, increased free radical production
may lead to the overconsumption of chain-breaking an-
tioxidants, elevated lipid peroxidation, and enhanced
oxidative stress [22]. Selenium is believed to be one of
the most important antioxidant nutrients in the human
body, and selenoproteins have a protective effect against
oxidative stress and inflammation [5, 8]. However, the
lower selenium status measured in T2DM populations
of some case–control studies might be caused by the
disease and its association with inflammation. Other
previous studies have suggested that the inflammatory
response decreases the expression of selenoprotein P
and reduces plasma selenium concentrations [48, 49].
Conversely, some studies report that patients with
T2DM have higher selenium concentrations compared
with healthy subjects, and that blood selenium levels
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Fig. 4 Nonlinear dose–response relationship between selenium and
T2DM. The middle line represents the odds ratio of T2DM compared
with reference (53.5 ug/l), and the upper and lower lines represent











































Fig. 3 Forest plot of OR for T2DM between different serum selenium categories and the lowest category (reference) in individual study
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expression of GPx1 in transgenic mice was found to
lead to the development of insulin resistance, hyper-
glycemia, hyperinsulinemia, and obesity. After knock-
ing out GPx1, both insulin-induced glucose uptake
and insulin sensitivity were improved [50–52]. This
was explained by GPx1 removing hydrogen peroxide, a
second messenger in the insulin signaling cascade, and
insulin binding to its receptor [14]. The same correl-
ation was also observed between increased erythrocyte
GPx1 activity and mild insulin resistance in pregnant
women [53]. Another selenoprotein, SeP, was also
shown to be related to insulin resistance by aggravat-
ing insulin resistance through impairing insulin signal-
ing [54]. Studies have revealed a significantly positive
association between SeP and fasting plasma glucose in
Japanese and Korean populations [54, 55]. Moreover,
in an earlier study, we found a significant positive
correlation between dietary selenium intake and the
prevalence of diabetes [56].
Previous review articles have suggested that the associ-
ation between selenium and T2DM is U-shaped, such
that selenoprotein levels both below and above the
physiological range are possible risk factors for T2DM
[5, 8, 12]. This estimation is consistent with our non-
linear dose–response analysis. We observed a moder-
ately positive association between selenium and T2DM
in individuals with relatively low levels of serum selen-
ium (<100 μg/l), a non-significant association between
selenium and T2DM in individuals with middle levels of
serum selenium (100–130 μg/l), and a strongly positive
association in individuals with relatively high levels of
serum selenium (>130 μg/l). Stranges et al. [37] con-
cluded that selenium supplementation does not prevent
T2DM, but may instead increase the disease risk in pop-
ulations with a median serum selenium level of 136 μg/l.
Another study suggested that both high and low expres-
sion levels of GPx1 and other related selenoproteins are
harmful because of their effects on insulin resistance
and hyperglycemia [57].
The present study has several strengths. It is the first
meta-analysis to perform a systematic and quantitative
analysis of the association between serum/plasma selen-
ium levels and T2DM. Several review articles [5, 8, 12]
have attempted to examine this relationship, but none
performed a quantitative analysis. Second, this study
showed a specific non-linear dose–response relationship
between serum selenium levels and T2DM. However, the
limitations of the present study should also be acknowl-
edged. The number of studies included in the analysis was
very limited. Second, the shortage of prospective cohort
studies could explain the causal relationship between sel-
enium and T2DM. Therefore, future prospective cohort
studies are needed to further explore this relationship.
Finally, because glucose levels vary greatly in patients with
T2DM, direct correlations of selenium levels with glucose
levels would provide us with relevant information. Unfor-
tunately, only two studies [27, 32] have reported these
data. Additionally, the search strategy and included studies
required for these analyses would differ from those of the
present meta-analysis. Thus, this would best be examined
as part of a future study.
Conclusion
In conclusion, we detected a positive association be-
tween serum selenium levels and T2DM in populations
with relatively low and high serum levels of selenium, re-
vealing a U-shaped non-linear dose–response relation-
ship between serum selenium and T2DM.
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